Ovid Therapeutics Inc Capital Reinvestment Ratio
Ovid Therapeutics Inc capital reinvestment ratio. Ovid Therapeutics Inc (OVID) has a Capital Reinvestment Ratio of 0.00x as of March 2021, meaning it reinvests 0% of its operating cash flow ($160.90 Million) in capital expenditures ($11.51K). Check Ovid Therapeutics Inc (OVID) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ovid Therapeutics Inc (2021–2021)
Capital reinvestment ratio of Ovid Therapeutics Inc from 2021 to 2021. This chart tracks Ovid Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore OVID net asset momentum to track the company's year-over-year net asset growth rate.
Ovid Therapeutics Inc Capital Reinvestment Ratio by Year (2021–2021)
Ovid Therapeutics Inc capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see OVID cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $118.61 Million | $189.41K | — |